
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial
Iain B. McInnes, Joachim Sieper, J. Braun, et al.
Annals of the Rheumatic Diseases (2013) Vol. 73, Iss. 2, pp. 349-356
Open Access | Times Cited: 335
Iain B. McInnes, Joachim Sieper, J. Braun, et al.
Annals of the Rheumatic Diseases (2013) Vol. 73, Iss. 2, pp. 349-356
Open Access | Times Cited: 335
Showing 1-25 of 335 citing articles:
10 Years of GWAS Discovery: Biology, Function, and Translation
Peter M. Visscher, Naomi R. Wray, Qian Zhang, et al.
The American Journal of Human Genetics (2017) Vol. 101, Iss. 1, pp. 5-22
Open Access | Times Cited: 3389
Peter M. Visscher, Naomi R. Wray, Qian Zhang, et al.
The American Journal of Human Genetics (2017) Vol. 101, Iss. 1, pp. 5-22
Open Access | Times Cited: 3389
The IL-17 Family of Cytokines in Health and Disease
Mandy J. McGeachy, J. Daniel, Sarah L. Gaffen
Immunity (2019) Vol. 50, Iss. 4, pp. 892-906
Open Access | Times Cited: 1088
Mandy J. McGeachy, J. Daniel, Sarah L. Gaffen
Immunity (2019) Vol. 50, Iss. 4, pp. 892-906
Open Access | Times Cited: 1088
Psoriatic Arthritis
Christopher T. Ritchlin, Robert A. Colbert, Dafna D. Gladman
New England Journal of Medicine (2017) Vol. 376, Iss. 10, pp. 957-970
Closed Access | Times Cited: 1088
Christopher T. Ritchlin, Robert A. Colbert, Dafna D. Gladman
New England Journal of Medicine (2017) Vol. 376, Iss. 10, pp. 957-970
Closed Access | Times Cited: 1088
European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update
Laure Gossec, Josef S Smolen, Sofía Ramiro, et al.
Annals of the Rheumatic Diseases (2015) Vol. 75, Iss. 3, pp. 499-510
Open Access | Times Cited: 885
Laure Gossec, Josef S Smolen, Sofía Ramiro, et al.
Annals of the Rheumatic Diseases (2015) Vol. 75, Iss. 3, pp. 499-510
Open Access | Times Cited: 885
IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases
Michele W.L. Teng, Edward P. Bowman, Joshua McElwee, et al.
Nature Medicine (2015) Vol. 21, Iss. 7, pp. 719-729
Closed Access | Times Cited: 779
Michele W.L. Teng, Edward P. Bowman, Joshua McElwee, et al.
Nature Medicine (2015) Vol. 21, Iss. 7, pp. 719-729
Closed Access | Times Cited: 779
Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis
Philip J. Mease, Iain B. McInnes, Bruce Kirkham, et al.
New England Journal of Medicine (2015) Vol. 373, Iss. 14, pp. 1329-1339
Open Access | Times Cited: 683
Philip J. Mease, Iain B. McInnes, Bruce Kirkham, et al.
New England Journal of Medicine (2015) Vol. 373, Iss. 14, pp. 1329-1339
Open Access | Times Cited: 683
Osteoimmunology: The Conceptual Framework Unifying the Immune and Skeletal Systems
Kazuo Okamoto, Tomoki Nakashima, Masahiro Shinohara, et al.
Physiological Reviews (2017) Vol. 97, Iss. 4, pp. 1295-1349
Open Access | Times Cited: 439
Kazuo Okamoto, Tomoki Nakashima, Masahiro Shinohara, et al.
Physiological Reviews (2017) Vol. 97, Iss. 4, pp. 1295-1349
Open Access | Times Cited: 439
2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis
Jasvinder A. Singh, Gordon Guyatt, Alexis Ogdie, et al.
Arthritis Care & Research (2018) Vol. 71, Iss. 1, pp. 2-29
Open Access | Times Cited: 435
Jasvinder A. Singh, Gordon Guyatt, Alexis Ogdie, et al.
Arthritis Care & Research (2018) Vol. 71, Iss. 1, pp. 2-29
Open Access | Times Cited: 435
Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges
Josef S Smolen, Daniel Aletaha
Nature Reviews Rheumatology (2015) Vol. 11, Iss. 5, pp. 276-289
Closed Access | Times Cited: 432
Josef S Smolen, Daniel Aletaha
Nature Reviews Rheumatology (2015) Vol. 11, Iss. 5, pp. 276-289
Closed Access | Times Cited: 432
Interleukin 17 is a chief orchestrator of immunity
Marc Veldhoen
Nature Immunology (2017) Vol. 18, Iss. 6, pp. 612-621
Closed Access | Times Cited: 415
Marc Veldhoen
Nature Immunology (2017) Vol. 18, Iss. 6, pp. 612-621
Closed Access | Times Cited: 415
2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis
Jasvinder A. Singh, Gordon Guyatt, Alexis Ogdie, et al.
Arthritis & Rheumatology (2018) Vol. 71, Iss. 1, pp. 5-32
Open Access | Times Cited: 395
Jasvinder A. Singh, Gordon Guyatt, Alexis Ogdie, et al.
Arthritis & Rheumatology (2018) Vol. 71, Iss. 1, pp. 5-32
Open Access | Times Cited: 395
Management of psoriasis as a systemic disease: what is the evidence?
Neil J. Korman
British Journal of Dermatology (2019) Vol. 182, Iss. 4, pp. 840-848
Open Access | Times Cited: 387
Neil J. Korman
British Journal of Dermatology (2019) Vol. 182, Iss. 4, pp. 840-848
Open Access | Times Cited: 387
Brodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis
Philip J. Mease, Mark C. Genovese, Maria Greenwald, et al.
New England Journal of Medicine (2014) Vol. 370, Iss. 24, pp. 2295-2306
Open Access | Times Cited: 376
Philip J. Mease, Mark C. Genovese, Maria Greenwald, et al.
New England Journal of Medicine (2014) Vol. 370, Iss. 24, pp. 2295-2306
Open Access | Times Cited: 376
IL-17 in Chronic Inflammation: From Discovery to Targeting
Audrey Beringer, Mélissa Noack, Pierre Miossec
Trends in Molecular Medicine (2016) Vol. 22, Iss. 3, pp. 230-241
Closed Access | Times Cited: 376
Audrey Beringer, Mélissa Noack, Pierre Miossec
Trends in Molecular Medicine (2016) Vol. 22, Iss. 3, pp. 230-241
Closed Access | Times Cited: 376
Interleukin-17 and innate immunity in infections and chronic inflammation
Natasa Isailovic, Kenji Daigo, Alberto Mantovani, et al.
Journal of Autoimmunity (2015) Vol. 60, pp. 1-11
Closed Access | Times Cited: 346
Natasa Isailovic, Kenji Daigo, Alberto Mantovani, et al.
Journal of Autoimmunity (2015) Vol. 60, pp. 1-11
Closed Access | Times Cited: 346
Diagnosis and classification of psoriasis
Smriti K. Raychaudhuri, Emanual Maverakis, S. P. Raychaudhuri
Autoimmunity Reviews (2014) Vol. 13, Iss. 4-5, pp. 490-495
Closed Access | Times Cited: 335
Smriti K. Raychaudhuri, Emanual Maverakis, S. P. Raychaudhuri
Autoimmunity Reviews (2014) Vol. 13, Iss. 4-5, pp. 490-495
Closed Access | Times Cited: 335
Psoriasis: Which therapy for which patient
Shivani B. Kaushik, Mark Lebwohl
Journal of the American Academy of Dermatology (2018) Vol. 80, Iss. 1, pp. 27-40
Closed Access | Times Cited: 318
Shivani B. Kaushik, Mark Lebwohl
Journal of the American Academy of Dermatology (2018) Vol. 80, Iss. 1, pp. 27-40
Closed Access | Times Cited: 318
Cytokines as Therapeutic Targets in Rheumatoid Arthritis and Other Inflammatory Diseases
Stefan Siebert, Alexander Tsoukas, Jamie Robertson, et al.
Pharmacological Reviews (2015) Vol. 67, Iss. 2, pp. 280-309
Open Access | Times Cited: 296
Stefan Siebert, Alexander Tsoukas, Jamie Robertson, et al.
Pharmacological Reviews (2015) Vol. 67, Iss. 2, pp. 280-309
Open Access | Times Cited: 296
Interleukin‐17+CD8+ T Cells Are Enriched in the Joints of Patients With Psoriatic Arthritis and Correlate With Disease Activity and Joint Damage Progression
Bina Menon, Nicola Gullick, Gina Walter, et al.
Arthritis & Rheumatology (2014) Vol. 66, Iss. 5, pp. 1272-1281
Open Access | Times Cited: 258
Bina Menon, Nicola Gullick, Gina Walter, et al.
Arthritis & Rheumatology (2014) Vol. 66, Iss. 5, pp. 1272-1281
Open Access | Times Cited: 258
Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 study
Philip J. Mease, Désirée van der Heijde, Robert Landewé, et al.
Annals of the Rheumatic Diseases (2018), pp. annrheumdis-212687
Open Access | Times Cited: 249
Philip J. Mease, Désirée van der Heijde, Robert Landewé, et al.
Annals of the Rheumatic Diseases (2018), pp. annrheumdis-212687
Open Access | Times Cited: 249
Managing Patients with Psoriatic Disease: The Diagnosis and Pharmacologic Treatment of Psoriatic Arthritis in Patients with Psoriasis
Philip J. Mease, April W. Armstrong
Drugs (2014) Vol. 74, Iss. 4, pp. 423-441
Open Access | Times Cited: 247
Philip J. Mease, April W. Armstrong
Drugs (2014) Vol. 74, Iss. 4, pp. 423-441
Open Access | Times Cited: 247
Candida infections in patients with psoriasis and psoriatic arthritis treated with interleukin-17 inhibitors and their practical management
Ditte Marie Lindhardt Saunte, Ulrich Mrowietz, L. Puig, et al.
British Journal of Dermatology (2016) Vol. 177, Iss. 1, pp. 47-62
Closed Access | Times Cited: 238
Ditte Marie Lindhardt Saunte, Ulrich Mrowietz, L. Puig, et al.
British Journal of Dermatology (2016) Vol. 177, Iss. 1, pp. 47-62
Closed Access | Times Cited: 238
Interleukin‐17A: a unique pathway in immune‐mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis
Bruce Kirkham, Arthur Kavanaugh, Kristian Reich
Immunology (2013) Vol. 141, Iss. 2, pp. 133-142
Open Access | Times Cited: 226
Bruce Kirkham, Arthur Kavanaugh, Kristian Reich
Immunology (2013) Vol. 141, Iss. 2, pp. 133-142
Open Access | Times Cited: 226
Ankylosing spondylitis: an autoimmune or autoinflammatory disease?
Daniele Mauro, Ranjeny Thomas, Giuliana Guggino, et al.
Nature Reviews Rheumatology (2021) Vol. 17, Iss. 7, pp. 387-404
Closed Access | Times Cited: 225
Daniele Mauro, Ranjeny Thomas, Giuliana Guggino, et al.
Nature Reviews Rheumatology (2021) Vol. 17, Iss. 7, pp. 387-404
Closed Access | Times Cited: 225
Heterogeneity of autoimmune diseases: pathophysiologic insights from genetics and implications for new therapies
Judy H. Cho, M Feldman
Nature Medicine (2015) Vol. 21, Iss. 7, pp. 730-738
Open Access | Times Cited: 220
Judy H. Cho, M Feldman
Nature Medicine (2015) Vol. 21, Iss. 7, pp. 730-738
Open Access | Times Cited: 220